chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up next morning with right upper eyelid swollen to the point I could barely open my right eye.; Approx. 5 hours post vaccination, my right upper eyelid began to hurt, continued up to a 7/10 pain scale.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 32 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Aug2021 12:30 (Lot number: EW0168) at the age of 32 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Psoriasis" (unspecified if ongoing); "Psoriasis/Psoriatic Arthritis" (unspecified if ongoing); "Crohn's/Colitis" (unspecified if ongoing); "Crohn's/Colitis" (unspecified if ongoing); "Thyroid Cancer" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE; AVSOLA [INFLIXIMAB]; FLUVOXAMINE; AMITIZA. The following information was reported: EYELID PAIN (non-serious) with onset 17Aug2021 17:30, outcome "recovering", described as "Approx. 5 hours post vaccination, my right upper eyelid began to hurt, continued up to a 7/10 pain scale."; SWELLING OF EYELID (non-serious) with onset 18Aug2021, outcome "recovering", described as "Woke up next morning with right upper eyelid swollen to the point I could barely open my right eye.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of eyelid pain, swelling of eyelid.  Additional information: no other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. No Known allergies.  No follow-up attempts are possible. No further information is expected.
ADMINISTERED IN LEFT THIGH MUSCLE. REPORTED FEVER OF 103DEGREES FOR 2 DAYS. SMALL RED AREA AT INJECTION SIGHT, 2 INCHES AWAY WAS FEVERISH AREA SIZE OF SMALL ORANGE. MUSCLE SORENESS TO THE POINT OF BEING UNABLE TO WALK ON LEG FOR 3 DAYS. ALL SYMPTOMS RESOLVED ON THEIR ON OWN IN 6 DAYS. USED TYLENOL AND HEAT/COLD FOR COMFORT AND FEVER.
How long does headache last; This case was reported by a consumer and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrix, the patient experienced headache. The reporter asked, how long does headache last after shingles vaccine.
Developed hives on left arm with some redness and swelling about 5 minutes after administration. Given 12.5ml of Benadryl in the office with improvement and no further spread of rash or any other allergic reaction. Eating and drinking well in the office and active.
Have pain at the site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left, administration date 24Feb2021 (Lot number: GL9266) at the age of 68 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "cholesterol" (unspecified if ongoing); "Acid Reflux" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN taken for blood cholesterol (ongoing); OMEPRAZOLE taken for gastrooesophageal reflux disease; FLORASTOR [SACCHAROMYCES BOULARDII]; CENTRUM A TO ZINC; VITAMIN D3 1000. Vaccination history included: Flu shot, for flu immunisation; Shingles shot, for immunisation; Pneumonia shot, for immunisation. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "Have pain at the site". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
small rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (small rash at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE RASH (small rash at the injection site). At the time of the report, VACCINATION SITE RASH (small rash at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Drowsy, headache that lasted through the next day, chills, and hot flashes, nausea, loss of appetite, water tasted funny. Effects lasted through the next day. Headache still upon awaking on the 15th. Used tylenol and excedrin for the headache and an attempt to control chills hot flashes, they only helped with the headaches.
Diffuse urticaria and erythematous wheals, between 1-2 cm in size, covering arms, legs, and torso. Rash is worse on back. Mild itching. Taking Benadryl every 4-6 hours.
local rxn 4cm of indurated, red skin below site of inj lt deltoid;
1. day: fever, fatigue, chills, elevated blood pressure, dizziness 2. day: fatigue, chills, dizziness, elevated blood pressure, fingers turned white, hands tingling From 3. day until now: fatigue, dizziness, elevated blood pressure, fingers still white, hands tingling
Persistent intermittent numbness and tingling of left dorsal forearm, beginning very soon after the immunization in that arm.
Approx 4 hours after shot had hot flashes and mild dizziness for about half an hour. Sat down for 15 min & it subsided. 2 hours later started to feel extremely fatigued & pain in left arm. Flu like symptoms & arm pain through the night & next morning. Morning of day after shot also had lower back pain on left side. Back & arm pain continued intermittently through the 2nd day. Took extra strength Tylenol.  3rd day had minor fatigue, diminished arm pain, worse back pain.  Pain in arm & back worsened at night & unable to find comfortable sleeping position.  Used spray muscle reliever.  Morning of 4th day had minor back pain. Used heating pad a few times & pain is now mostly gone.  Flu like symptoms also gone.
Felt very euphoric after getting the vaccine.; Her eyes would barely open and were bothering her; 2 days later she started throwing up and she threw up for 4 days straight.; She passed out for 4 days; I had a horrible reaction. I thought I was dying/She said that she thought she was going to die; This is a spontaneous report from a contactable consumer (patient)  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 04May2021 (Batch/Lot Number: EW0175) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient took COVID19 Vaccine Pfizer and started suffering issues, she had bad reactions to the vaccine. The patient said that she had the vaccine and felt very euphoric after getting it; she said that they gave her a bottle of water and she stayed at the vaccine location for 20 minutes and felt so good that she actually bought some make up. The patient said that after that she went home and she passed out for 4 days and after she woke up, she said that her eyes would barely open and were bothering her. 2 days later she started throwing up and she threw up for 4 days straight. The patient called her doctor and her doctor told her to drink Gatorade and she did, and felt better. The patient said that she thought she was going to die. It was very frightening and she was very concerned about taking the second dose. It was also reported that "she had a antibody test and she has 50 antibodies and the pharmacist told her it was very high". The outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
This initial spontaneous report was received on 19-JAN-2017 from a female licensed practical nurse (LPN) who reported that multiple unspecified patients "over 14 years of age" received either dose 2 or dose 3 of GARDASIL 9 one to two years after receiving the previous dose of GARDASIL 9 (unspecified dates) which is outside of the recommendations in the GARDASIL 9 prescribing information. The vaccination(s) route, site, Lot #, expiration date and indication were not reported. No adverse effect reported. No further information was reported. Additional information received on 20-JAN-2017, from the same female licensed practical nurse (LPN) reported the date(s) of the administration of GARDASIL 9 for this female (age unknown) were reported to be  1) 18-JUN-2014 and 2) 27-JUL-2016. No further information was reported. Additional information has been requested. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1701USA009269: US-009507513-1701USA009269: US-009507513-1701USA009269.
4/13/2011 pt presents to clinic stating that she is pregnant. She was previously told by her MD that her estrogen levels were low and she would probably not get pregnant. RN referred pt to prenatal clinic. On 5/9/11 pt reported to RN that she had a spontaneous abortion. Fetus was approximately 6-7 weeks old.
The arm were the vaccine was administered is swelling not the injection site; Soreness in the elbow,Elbow still a little swell; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (The arm were the vaccine was administered is swelling not the injection site) and JOINT SWELLING (Soreness in the elbow,Elbow still a little swell) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022N2QA) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE SWELLING (The arm were the vaccine was administered is swelling not the injection site) and JOINT SWELLING (Soreness in the elbow,Elbow still a little swell). At the time of the report, VACCINATION SITE SWELLING (The arm were the vaccine was administered is swelling not the injection site) and JOINT SWELLING (Soreness in the elbow,Elbow still a little swell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient has little soreness in the elbow before receiving the vaccine. No relevant concomitant medications were reported. No treatment information was reported.
Really tired for 3 weeks following the shot; Sick; Weak; Sleepy and couldn't stay awake; This is a spontaneous report from a contactable consumer (patient's daughter). An 82-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Unknown, Expiration date: Unknown), via an unspecified route of administration on an unspecified date, at the age of 82-years-old, as single dose for COVID-19 immunisation. Medical history included ongoing blood pressure; suffered from cramps (ongoing). The patient was in good health Family medical history was none. Concomitant medication included blood pressure medication for blood pressure from an unspecified date and ongoing. No additional vaccines administered on same date of the Pfizer suspect. The patient had no prior vaccinations (within 4 weeks). It was reported that the patient was really tired for 3 weeks following the shot. He was sick and weak. He was sleepy and just could not stay awake. Right after the patient got the shot, his symptoms started. The patient did not go to the doctor or the ER. He just got through it. He had no relevant tests done. Outcome of the events was unknown.  Information on lot/batch number has been requested.
I contracted COVID-19 on 06/22/2022 with symptoms of swollen tonsils, fever of 101, loss of taste, loss of smell, fatigue, runny nose, runny eyes, congestion, and cough. I was given the monoclonal antibody infusion on 06/28/2022. I was ill for 4 to 5 days before my symptoms began to resolve. I am fully recovered with no lingering symptoms.
More than likely, this is due to his current COVID-19 illness. fever, diarrhea, weakness
her blood count showed zero platelets; heavy vaginal bleeding; red spots under ankle and wrists; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOCYTOPENIA (her blood count showed zero platelets) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOCYTOPENIA (her blood count showed zero platelets) (seriousness criteria hospitalization and medically significant), VAGINAL HAEMORRHAGE (heavy vaginal bleeding) and PURPURA (red spots under ankle and wrists). At the time of the report, THROMBOCYTOPENIA (her blood count showed zero platelets), VAGINAL HAEMORRHAGE (heavy vaginal bleeding) and PURPURA (red spots under ankle and wrists) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: abnormal (abnormal) blood count showed zero platelets and normal (normal) completely normal blood-test results less than a week before being vaccinated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had a checkup with completely normal blood-test results less than a week before being vaccinated. Patient had spent four days in the hospital, receiving platelet transfusions, immune globulins and steroids to restore her platelet count. Concomitant medication were not provided.  Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded. Further information has been requested   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Patient was a 30 minute observation due to hx of anaphylaxis with bee's.  15 min post vaccination, patient stated "Short of breath and my throat is tight".  HR 77, O2 94%, wheezy.  gave 0.3 ml epi in  left thigh, immediately transferred to ER
I am calling to see if it's common that you have increasing fatigue after five days after your shot. I got my shot on Friday, my first one.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "I am calling to see if it's common that you have increasing fatigue after five days after your shot. I got my shot on Friday, my first one.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax JUL95 & 11JUN97 pt devel chickenpox & broke out for 9 days straight;pt had too many to count, they stopped counting @ 170;they broke open & crusted;had high fever of 103.6;taken to MD;
Patient developed hip and shoulder pain three days after vaccination which gradually worsened.  She had weakness to the point of difficulty walking.  Was seen in the ED on 11/18, ESR 32 and was diagnosed with myofascial pain. Was seen in office 12/4 with suspicion for polymyalgia rheumatica.  ESR at that time was 54 and CRP 7.8 with normal CPK.  Started on prednisone 15mg daily with complete resolution in her symptoms by follow up visit 12/19.
Routine pneumococcal vaccination given into Lt shoulder. Immediate shooting pain, pain progressively worsened throughout the day leading to excruciating within 6 hours later, radiation to Lt upper back and neck. Unable to sleep, lost all ROM of shoulder for several days. Tried rounds of oral steroids, intra-articular steroids, PT, ibuprofen without relief. Surgery to improve impingement now (9 mo later) scheduled. Daily numbness, tingling, burning of Lt shoulder to hand with decreased grip strength. Changes on MRI consistent with acute insult.
Fever, body aches, very sore arm, headache, fatigue for 24 hours
Vaccine Breakthrough   COVID + 7/31/21.  Inpatient hospitalization for acute respiratory failure in ICU
DTAP, MMR, IPV was given 03/08/04 at 10:45.  Mom called at 12:45: complained of hives, and vomiting.  No respiratory distress.  Referred to ER, diagnosis of allergic reaction.  No meds given.  Per mom hives and vomiting stopped at 15:00.
Several papular lesions on body, 1-2 appear vesicular.  Diagnosis: Varicella  Treatment: Symptomatic
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated   with improperly stored doses of ROTATEQ orally (lot #  not reported) exposed to 32F for 30 hours. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
first Shingrix in 2019, never received second; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first Shingrix vaccine in 2019, in an unknown arm Intramuscular).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK Receipt Date: 12-May-2022 Reporter's Comments: The pharmacist reported that her patient received her first Shingrix vaccine in 2019, and  never received the second Shingrix vaccine (Inappropriate Schedule of Vaccine). The reporter did not consent to follow-up.  Additional Supportive Information: The patient did not received 2nd dose till the time of reporting which led to incomplete course of vaccination.
MY ARM ONLY SORE WHEN I TOUCH  THE SITE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) once a total dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced arm only sore when i touch the site. The action taken with covid-19 vaccine was not applicable. The outcome of arm only sore when i touch the site was not reported. This report was non-serious.
This is a spontaneous report from a contactable consumer received via a Pfizer sales representative. This consumer reported similar events for two patients. This is the second of two reports. A male patient of an unspecified age and ethnicity received TRUMENBA, (batch/lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced pain injection site on an unspecified date. The outcome of the event was unknown. The information on the batch/lot number and expiration date has been requested. Sender's Comments: Linked Report(s) : US-PFIZER INC-2018163421 same reporter/drug/event, different patient.
Low grade Fever on Saturday and lethargic. Sunday no symptoms. Monday fever of 101° back pain, chills, headache.
Pt developed erythema, warmth and tenderness of injection site of pneumovax within 48 hours. She was admitted to the hospital by another MD after worsening cellulitis. She recovered completely.
As usual, my arm was sore and hurt after the shot. It felt this way for several days. I noticed a redness in the shot area. After a while, the symptoms went away, but now it's a week later and my arm is hurting so much that I had trouble sleeping. The pain is where I got the shot & is radiating down the arm. I plan to call the doctor today.
I was given my shot, I had this warm feeling in my head, migraine left and I have not had one since; I was given my shot, I had this warm feeling in my head, migraine left and I have not had one since; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "had terrible migraines", start date: Jan2021 (unspecified if ongoing), notes: lasting everyday for weeks. My doctor thought it might be iritis but, the steroid drops did not help. I tried a new migraine medicine and it did nothing. The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), FEELING HOT (non-serious), outcome "unknown" and all described as "I was given my shot, I had this warm feeling in my head, migraine left and I have not had one since". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Last January patient had terrible migraines lasting everyday for weeks. Sunglasses in house and windows and door covered. Patient doctor thought it might be iritis but the steroid drops did not help. Patient tried a new migraine medicine and it did nothing. Patient went the next day for blood work and was given a different medicine. Patient told doctor patient was getting Covid shot next day so patient would take it after 3 days. Patient was given shot, patient had this warm feeling in patient head, migraine left and patient have not had one since.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse referring to a female patient of unknown age. Information regarding concurrent conditions and medical history was not provided. On 06-JUL-2015 the patient was vaccinated with a dose of GARDASIL that was improperly stored, lot # K008931, exp. date: 04-MAR-2017, dose/frequency: single dose vaccination, intramuscularly (injection site was not reported). Concomitant therapy was not reported. No adverse effects reported. Additional information has been requested.
I felt lightheaded. Nurse said I turned pale. Asked me to take a juice box, eat crackers. Meanwhile a nurse took my blood pressure: Started at 170/90, 5 min later 150/80 & when I left. 120/60. My oxygen had dropped to 75 - back to 93 ", pulse 88 to 80. Took about 45 min to feel ok.